Literature DB >> 14550468

Reperfusion of ischemic corporal tissue: physiologic and biochemical changes in an animal model of ischemic priapism.

Ricardo Munarriz1, Kwangsung Park, Yue-Hua Huang, Iñigo Saenz de Tejada, Robert B Moreland, Irwin Goldstein, Abdulmaged M Traish.   

Abstract

OBJECTIVES: To assess the physiologic and biochemical changes resulting from ischemia and reperfusion. Effective therapy for ischemic priapism reestablishes corporal venous outflow and arterial inflow and results in increased corporal partial pressure of oxygen. Data are limited concerning reperfusion injury of ischemic erectile tissue associated with reactive oxygen species (ROS) and the potential role of ROS scavengers in the clinical therapy of ischemic priapism.
METHODS: Anesthetized adult New Zealand white male rabbits (n = 7) were exposed to a low oxygen tension breathing gas to achieve hypoxia within the corpora cavernosa. This resulted in a mean systemic oxygen saturation of 60%. The pelvic nerve was electrically stimulated to induce penile erection, and the base of the erect penis was clamped. After varying durations of ischemia, the clamp was removed to allow reperfusion. We determined the intracavernosal oxygen tension, histologic changes, myeloperoxidase activity, and lipid peroxidation.
RESULTS: Corporal partial pressure of oxygen progressively decreased as the duration of priapism increased. A statistically significant increase was noted in myeloperoxidase activity and lipid peroxidation with corporal reperfusion. Polymorphonuclear leukocyte infiltration was documented in the ischemic reperfused tissue.
CONCLUSIONS: In the management of ischemic priapism, reperfusion causes erectile tissue injury owing to the presence of ROS. There is a need to investigate the utility of ROS scavengers and antioxidants in the management of ischemic priapism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550468     DOI: 10.1016/s0090-4295(03)00484-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  17 in total

1.  The effects of oxytocin on penile tissues in experimental priapism model in rats.

Authors:  Engin Kolukcu; Sahin Kilic; Bekir Suha Parlaktas; Fikret Erdemir; Velid Unsal; Dogan Atılgan; Nihat Uluocak
Journal:  Int Urol Nephrol       Date:  2018-12-04       Impact factor: 2.370

Review 2.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

3.  Nitrergic Mechanisms for Management of Recurrent Priapism.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  Sex Med Rev       Date:  2015-06-04

Review 4.  Physiological ischemia/reperfusion phenomena and their relation to endogenous melatonin production: a hypothesis.

Authors:  Dun-Xian Tan; Lucien C Manchester; Rosa M Sainz; Juan C Mayo; Josefa León; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

5.  An animal model of ischemic priapism and the effects of melatonin on antioxidant enzymes and oxidative injury parameters in rat penis.

Authors:  Nihat Uluocak; Dogan Atılgan; Fikret Erdemir; Bekir S Parlaktas; Adem Yasar; Unal Erkorkmaz; Ali Akbas
Journal:  Int Urol Nephrol       Date:  2010-01-30       Impact factor: 2.370

6.  Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism.

Authors:  Gwen Lagoda; Sena F Sezen; K Joseph Hurt; Marcelo R Cabrini; Dillip K Mohanty; Arthur L Burnett
Journal:  FASEB J       Date:  2013-09-27       Impact factor: 5.191

7.  Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.

Authors:  Uzoma A Anele; Arthur L Burnett
Journal:  J Sex Med       Date:  2015-01-09       Impact factor: 3.802

Review 8.  Review of Ischemic and Non-ischemic Priapism.

Authors:  Mark G Biebel; Martin S Gross; Ricardo Munarriz
Journal:  Curr Urol Rep       Date:  2022-05-10       Impact factor: 3.092

9.  Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.

Authors:  Trinity J Bivalacqua; Biljana Musicki; Lewis L Hsu; Mark T Gladwin; Arthur L Burnett; Hunter C Champion
Journal:  J Sex Med       Date:  2009-06-11       Impact factor: 3.802

10.  Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.

Authors:  Trinity J Bivalacqua; Biljana Musicki; Lewis L Hsu; Dan E Berkowitz; Hunter C Champion; Arthur L Burnett
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.